Australia to ease regulatory burden for devices and drugs
This article was originally published in Clinica
Executive Summary
A small group of experts is to conduct an independent assessment of Australia's Therapeutic Goods Administration with a view to streamlining the agency's regulatory processes for medicines and medical devices, improving access to medicines, and boosting productivity and competitiveness.